Literature DB >> 7692472

Psychological distress in cancer patients with advanced disease.

S Kaasa1, U Malt, S Hagen, E Wist, T Moum, A Kvikstad.   

Abstract

The objective of this study is to explore the nature and extent of the cognitive behavioral response to treatment, and the accompanying anxiety and/or depression in cancer patients with advanced disease. In a multicenter study, 247 patients treated with palliative radiotherapy filled out a questionnaire before start of treatment. The questionnaire consisted of Impact of Event Scale (IES), General Health Questionnaire (GHQ-20), and two questions assessing pain intensity. Seventy percent of the patients reported a high level of psychological distress. The mean score of the patient population on the IES was 14.4 (IES intrusion) and 15.3 (IES avoidance). The mean Likert score on the GHQ-20 was 27.3. Patients with poor performance status and pain were most distressed. In order to improve patients' care and support, cases at risk must be identified. In the present population, psychological distress is related to pain and reduced performance status.

Entities:  

Mesh:

Year:  1993        PMID: 7692472     DOI: 10.1016/0167-8140(93)90073-h

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  28 in total

1.  Responsiveness to change [corrected] due to supportive-expressive group therapy, improvement in mood and disease progression in women with metastatic breast cancer.

Authors:  Julie Lemieux; Dorcas E Beaton; Sheilah Hogg-Johnson; Louise J Bordeleau; Jon Hunter; Pamela J Goodwin
Journal:  Qual Life Res       Date:  2007-05-15       Impact factor: 4.147

2.  Deconstructing the complexity of PTSD in cancer.

Authors:  Oxana Palesh; Cheryl Koopman
Journal:  Nat Rev Clin Oncol       Date:  2013-06-18       Impact factor: 66.675

3.  Psychometric testing of the Impact of Event Scale-Chinese Version (IES-C) in oral cancer patients in Taiwan.

Authors:  Shu-Ching Chen; Yeur-Hur Lai; Chun-Ta Liao; Chia-Chin Lin
Journal:  Support Care Cancer       Date:  2005-02-17       Impact factor: 3.603

4.  Anxiety, depression and quality of life in colorectal cancer patients.

Authors:  Akira Tsunoda; Kentaro Nakao; Kenshi Hiratsuka; Naokuni Yasuda; Miki Shibusawa; Mitsuo Kusano
Journal:  Int J Clin Oncol       Date:  2005-12       Impact factor: 3.402

5.  Psychological effects of chronic injury in elite athletes.

Authors:  M L Shuer; M S Dietrich
Journal:  West J Med       Date:  1997-02

Review 6.  The treatment of depression in cancer patients: a systematic review.

Authors:  Gary Rodin; Nancy Lloyd; Mark Katz; Esther Green; Jean A Mackay; Rebecca K S Wong
Journal:  Support Care Cancer       Date:  2006-10-21       Impact factor: 3.603

7.  Relevance of philosophy of life and optimism for psychological distress among individuals in a stage where death is approaching.

Authors:  Jeanette Winterling; Elisabet Wasteson; Birgitta Sidenvall; Erik Sidenvall; Bengt Glimelius; Per-Olow Sjödén; Karin Nordin
Journal:  Support Care Cancer       Date:  2005-08-03       Impact factor: 3.603

8.  Can telephone counseling post-treatment improve psychosocial outcomes among early stage breast cancer survivors?

Authors:  Alfred C Marcus; Kathleen M Garrett; David Cella; Lari Wenzel; Marianne J Brady; Diane Fairclough; Meredith Pate-Willig; Denise Barnes; Susan Powell Emsbo; Brenda C Kluhsman; Lori Crane; Scot Sedlacek; Patrick J Flynn
Journal:  Psychooncology       Date:  2010-09       Impact factor: 3.894

9.  Uncertainty and psychological adjustment in patients with lung cancer.

Authors:  Keiko Kurita; Edward B Garon; Annette L Stanton; Beth E Meyerowitz
Journal:  Psychooncology       Date:  2012-08-13       Impact factor: 3.894

10.  Colorectal cancer in the family: psychosocial distress and social issues in the years following genetic counselling.

Authors:  Eveline M A Bleiker; Fred H Menko; Irma Kluijt; Babs G Taal; Miranda A Gerritsma; Lidwina D V Wever; Neil K Aaronson
Journal:  Hered Cancer Clin Pract       Date:  2007-06-15       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.